YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Demographic, Clinical and Echocardiographic Characteristics of Patients With Rheumatic Mitral Stenosis Treated With Mitral Balloon Valvuloplasty Procedure: a Local Experince

dc.contributor.author Tüner, Haşim
dc.contributor.author Kaya, Yüksel
dc.contributor.author Tuncer, Mustafa
dc.date.accessioned 2025-05-10T17:57:33Z
dc.date.available 2025-05-10T17:57:33Z
dc.date.issued 2024
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp T.C. Sağlik Bakanliği,Van Yüzüncü Yil Üni̇versi̇tesi̇,T.C. Sağlik Bakanliği en_US
dc.description.abstract Objectives: Rheumatic mitral stenosis (RMS) remains a significant health challenge, particularly in low- and middleincome countries, due to limited access to preventive measures and timely treatment. Percutaneous mitral balloon valvuloplasty (PMBV) has become the preferred treatment for RMS, offering a less invasive alternative to surgical mitral valve replacement. This study aimed to evaluate the demographic, clinical, and echocardiographic characteristics of patients with RMS undergoing PMBV and to assess the procedural outcomes. Materials and Methods: This study included 52 patients who underwent PMBV RMS. Patients with non-RMS, incomplete patient files, or previous valve surgeries were excluded. Results: The procedural success rate was 87%, with better outcomes observed in patients with a Wilkins score ≤8 than in those with a score >8. PMBV resulted in a significant increase in mitral valve area (MVA) (from 1.18±0.19 cm² to 2.27±0.48 cm², p=0.001) and a decrease in both mean mitral valve gradient (from 12.82±3.5 mmHg to 5.97±2.04 mmHg, p=0.001) and maximum mitral valve gradient (from 27.12±14.0 mmHg to 12.70±3.1 mmHg, p=0.001). Although the procedure was generally safe, manageable complications, such as chordal rupture (1 case, 1.9%) and mitral regurgitation (MR) progression, were observed, particularly in patients with higher Wilkins scores. Conclusion: The significant improvements in MVA and reduced gradient observed in our study underscore the effectiveness of PMBV, even in patients with higher Wilkins scores. Although we observed manageable complications, such as chordal rupture and MR progression, the overall safety and efficacy of PMBV in our patient population highlight its value as a practical and effective treatment option for RMS in our clinical setting. These findings support the continued use of PMBV as a standard treatment approach in our region, potentially enhancing the quality of care for patients with this condition. en_US
dc.identifier.doi 10.32596/jucvm.galenos.2024.2024-14-72
dc.identifier.endpage 100 en_US
dc.identifier.issn 3062-0392
dc.identifier.issue 3 en_US
dc.identifier.scopusquality N/A
dc.identifier.startpage 91 en_US
dc.identifier.trdizinid 1281675
dc.identifier.uri https://doi.org/10.32596/jucvm.galenos.2024.2024-14-72
dc.identifier.uri https://search.trdizin.gov.tr/en/yayin/detay/1281675/demographic-clinical-and-echocardiographic-characteristics-of-patients-with-rheumatic-mitral-stenosis-treated-with-mitral-balloon-valvuloplasty-procedure-a-local-experince
dc.identifier.uri https://hdl.handle.net/20.500.14720/20034
dc.identifier.volume 12 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.relation.ispartof Journal of updates in cardiovascular medicine en_US
dc.relation.publicationcategory Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title Demographic, Clinical and Echocardiographic Characteristics of Patients With Rheumatic Mitral Stenosis Treated With Mitral Balloon Valvuloplasty Procedure: a Local Experince en_US
dc.type Article en_US

Files